European stock markets experienced a robust upward trajectory on Thursday, buoyed by a positive shift in inflation expectations following a notable decrease in oil prices. The Dow Jones Industrial Average also celebrated a new all-time high, signalling confidence among investors.
FTSE 100 and FTSE 250 Performance
The FTSE 100 closed the day with a gain of 68.26 points, representing a 0.7% increase, finishing at 10,529.89. Similarly, the FTSE 250 rose by 59.89 points, or 0.3%, to settle at 23,161.41. However, the AIM All-Share faced a slight dip, falling 5.45 points, or 0.7%, to 771.92.
Across the Atlantic, the Dow Jones climbed 0.9%, marking a significant record high. The S&P 500 also edged up by 0.2%, while the Nasdaq Composite saw a decrease of 0.4%. This mixed performance underlines the varying investor sentiments across different sectors.
Micron Technology’s Stock Surge
In the tech sector, Micron Technology saw its shares soar by an impressive 11% after the company released third-quarter results that exceeded Wall Street’s expectations. The ongoing surge in demand for memory bandwidth driven by artificial intelligence applications has positioned Micron as a major beneficiary in the tight computer memory market. Chief Executive Sanjay Mehrotra noted that AI’s “insatiable” demand for memory has considerably transformed the industry landscape.
Despite the overall positive sentiment in the market, oil prices remained relatively stable, with Brent crude for August delivery trading at $74.42 a barrel, up from $73.45 the previous day but still well below peak levels observed during recent geopolitical tensions.
European Equity Markets Reflect Optimism
In European markets, the CAC 40 in Paris concluded the day up by 0.6%, while the DAX 40 in Frankfurt advanced by 1.0%. Bayer’s shares surged by 19% after the US Supreme Court overturned a lower court ruling that had raised concerns over the company’s liability regarding its glyphosate-containing herbicide, Roundup. The court’s ruling, which sent a significant jury award back to state court, is expected to shield Bayer from a substantial number of future claims.
Analyst Richard Vosser from JPMorgan highlighted that this decision could cover around 80% of existing glyphosate litigation, suggesting a potential 15-20% rise in Bayer’s stock performance.
Currency Movements and Economic Indicators
In currency trading, the British pound strengthened against the US dollar, trading at 1.3213, up from 1.3167 the previous day. The euro also gained ground, rising to 1.1387 against the dollar, reflecting a broader trend of currency appreciation across European markets.
The US Commerce Department revealed that the Federal Reserve’s preferred inflation measure reached a three-year high in May, with the personal consumption expenditures price index climbing 4.1% year-on-year. This increase has raised concerns about potential monetary policy adjustments, though analysts suggest that the recent decline in oil prices may alleviate some inflationary pressures.
Corporate Highlights
Back in London, shares of 3i Group surged by 11% following strong sales figures from its key investment, Action. CEO Simon Borrows reported a like-for-like sales growth of 3.3% for the year, indicating a recovery from previous weather-related setbacks.
In other news, easyJet’s shares rose by 6.6% as the airline indicated a willingness to engage with potential suitor Castlelake, following the rejection of multiple takeover bids. Analysts noted that easyJet’s shift in stance might suggest a more open approach to discussions about its future.
Meanwhile, Moonpig’s stock increased by 2.5% after the retailer delivered results that exceeded expectations, alongside a dividend hike and plans for a new share buyback programme. ITV also saw its shares rise by 3.1% following reports of a deal with Comcast-owned Sky regarding its broadcast and streaming unit.
Why it Matters
The upward momentum observed in European and US markets indicates a growing investor confidence amidst a backdrop of stabilising inflation. As companies continue to adapt and respond to shifting economic conditions, the resilience demonstrated by major players like Micron and Bayer highlights the dynamic nature of the current market landscape. Investors remain watchful of how these trends will shape the overall economic recovery and influence corporate strategies in the months ahead.
